Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

心脏保护研究研究

Andrea Poli, Alberico Catapano

    Lancet (London, England)
    |February 14, 2003
    PubMed
    概括

    No abstract available in PubMed .

    相关实验视频

    相关概念视频

    您也可能阅读

    相关文章

    通过共同作者、期刊和引用图与本文相关的文章。

    排序
    Same author

    LDL-cholesterol distance to target: A practical tool for guiding lipid-lowering treatment decisions.

    Atherosclerosis plus·2026
    Same author

    The year in Cardiovascular Medicine 2025: the top 10 papers in dyslipidaemias.

    European heart journal·2026
    Same author

    Definition of maximum daily amounts of vitamins and minerals allowed in food supplements: scientific rationale and European regulatory frameworks.

    Archives of medical science : AMS·2025
    Same author

    Interpreting substitution models in nutritional epidemiology: the case for the protective role of NOVA 1 foods over the risk of NOVA 4.

    The Lancet. Planetary health·2025
    Same author

    Consensus document on the role of plasma triglycerides in cardiovascular disease from the Italian Society for the Study of Atherosclerosis (SISA).

    Nutrition, metabolism, and cardiovascular diseases : NMCD·2025
    Same author

    Physician and patient perspectives on the treatment of hypercholesterolaemia: a cross-sectional study to identify disconnects.

    Current medical research and opinion·2025
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    查看所有相关文章